Showing 2411-2420 of 18625 results for "".
Advancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
https://reachmd.com/programs/clinicians-roundtable/advancing-mpe-diagnosis-and-prognosis-clinical-value-of-biomarker-integration/35660/Cytology via thoracentesis remains the first-line approach for diagnosing malignant pleural effusion (MPE), yet its sensitivity is limited. leaving many patients undiagnosed or delayed in treatment. In this expert-led discussion, Dr. David Feller-Kopman explores the limitations of current diaExamining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
https://reachmd.com/programs/project-oncology/examining-real-world-ibrutinib-outcomes-in-rr-mcl-findings-from-a-danish-study/37209/A recent Danish population-based study evaluating real-world outcomes of ibrutinib in relapsed or refractory mantle cell lymphoma (MCL) found lower efficacy and tolerability compared to clinical trials, particularly among older patients and those with high-risk disease features. In this AudioAbstracBuilding a Multidisciplinary Approach to IgA Nephropathy Care
https://reachmd.com/programs/clinicians-roundtable/building-a-multidisciplinary-approach-to-iga-nephropathy-care/33210/IgA nephropathy (IgAN) presents with a wide range of clinical signs, making timely detection and coordinated care essential. This multidisciplinary approach to diagnosis and management can manifest in a number of ways, from clinical evaluation and laboratory testing to emerging biomarkers and evolviRedefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
https://reachmd.com/programs/project-oncology/redefining-first-line-care-exploring-immunotherapy-in-endometrial-cancer/36392/Endometrial cancer treatment is evolving, with immunotherapy now transforming first-line care for recurrent and advanced disease. Recent landmark trials demonstrate consistent benefits when combining immunotherapy with chemotherapy. Hear from Dr. Brian Slomovitz as he explains this a significSubcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
https://reachmd.com/programs/project-oncology/subcutaneous-cancer-immunotherapy-at-home-transforming-trials-and-patient-care/35772/As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the UFrom Confidence to Action: Exercise Self-Efficacy and Improved COPD Outcomes
https://reachmd.com/programs/frontlines-copd/from-confidence-to-action-exercise-self-efficacy-and-improved-copd-outcomes/35537/For patients with COPD, exercise self-efficacy has been associated with better functional outcomes and quality of life. A recent study explored whether the effects of technological interventions like pedometers, tailored goals, and motivational support were mediated by changes in these patients' exeAdvancing COPD Care: AI-Driven Tools for Enhanced Imaging
https://reachmd.com/programs/frontlines-copd/advancing-copd-care-ai-driven-tools-for-enhanced-imaging/35538/While measurement of functional small airway disease typically requires at least two CT scans, a new generative model shows promise for predicting the disease with just one scan. Dr. Muhammad Chaudhary, instructor of at the University of Alabama at Birmingham School of Medicine, joins us to discussADT Monotherapy for mHSPC: How to Identify the Right Patients
https://reachmd.com/programs/frontlines-prostate-cancer/adt-monotherapy-for-mhspc-how-to-identify-the-right-patients/32219/While initial evidence favors combination regimens for metastatic hormone-sensitive prostate cancer (mHSPC), findings suggest that approximately 20 percent of patients may still benefit from ADT alone, particularly those with indolent disease features such as low-volume metastases or favorable PSA kJournal Club: Height Improvement After Treatment
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-height-improvement-after-treatment/32406/Practical Dermatology Editorial Board member Peter Lio, MD, talks with Amy Paller, MD, about research into patients with severe atopic dermatitis and lower stature achieving significant improvement in height following treatment with dupilumab.Managing Iatrogenic Colon Perforations: Strategies and Considerations
https://reachmd.com/programs/gi-insights/managing-iatrogenic-colon-perforations-strategies-and-considerations/32747/Colonic perforations during colonoscopy are rare, but when they occur, taking swift and informed action is critical, particularly to avoid surgical intervention. Joining Dr. Peter Buch to offer his insights on perforation prevention, risk-reduction techniques, and repair strategies is Dr. Mark Benso